Security key
92511W108
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)
CUSIP: 92511W108
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 92,448,158
- Total 13F shares
- 18,643,979
- Share change
- +881,898
- Total reported value
- $135,914,431
- Put/Call ratio
- 103%
- Price per share
- $7.29
- Number of holders
- 73
- Value change
- +$6,591,352
- Number of buys
- 36
- Number of sells
- 25
Report period
Q2 2024
Institutions
73
Top holders
10
VRCA full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Verrica Pharmaceuticals Inc. SEC filings
Verrica Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92511W108
Recent filing periods:
Top shareholders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
3/4/5
13F
|
10%+ Owner · Company |
7.7%
from 13F
|
7,099,182
|
$51,398,078 | — | 27 Dec 2023 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
4.3%
|
3,999,999
|
$23,679,994 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
1.6%
|
1,509,249
|
$8,934,754 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.4%
|
1,268,710
|
$7,510,763 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.2%
|
1,114,060
|
$6,595,236 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.49%
|
449,309
|
$2,660,217 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.45%
|
412,603
|
$2,442,610 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.21%
|
198,722
|
$1,176,434 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.2%
|
183,574
|
$1,086,758 | — | 31 Mar 2024 | |
| BML Capital Management, LLC |
13F
|
Company |
0.19%
|
180,000
|
$1,065,600 | — | 31 Mar 2024 | |
| SteelPeak Wealth, LLC |
13F
|
Company |
0.15%
|
137,936
|
$816,582 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.15%
|
134,216
|
$794,558 | — | 31 Mar 2024 | |
| Composition Wealth, LLC |
13F
|
Company |
0.13%
|
118,221
|
$699,868 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.11%
|
102,385
|
$606,119 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.1%
|
95,032
|
$562,589 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
82,200
|
$486,624 | — | 31 Mar 2024 | |
| KORNITZER CAPITAL MANAGEMENT INC /KS |
13F
|
Company |
0.08%
|
74,251
|
$439,566 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.06%
|
55,356
|
$327,708 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.06%
|
54,287
|
$321,379 | — | 31 Mar 2024 | |
| Kovitz Investment Group Partners, LLC |
13F
|
Company |
0.05%
|
50,125
|
$296,740 | — | 31 Mar 2024 | |
| BECK MACK & OLIVER LLC |
13F
|
Company |
0.03%
|
30,000
|
$177,600 | — | 31 Mar 2024 | |
| SPC Financial, Inc. |
13F
|
Company |
0.03%
|
30,000
|
$177,600 | — | 31 Mar 2024 | |
| MML INVESTORS SERVICES, LLC |
13F
|
Company |
0.03%
|
27,312
|
$162,000 | — | 31 Mar 2024 | |
| J. Goldman & Co LP |
13F
|
Company |
0.03%
|
27,000
|
$159,840 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
26,969
|
$159,656 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.03%
|
25,089
|
$148,527 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
22,332
|
$132,205 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
22,077
|
$130,688 | — | 31 Mar 2024 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.02%
|
20,500
|
$121,360 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
19,555
|
$115,766 | — | 31 Mar 2024 | |
| Creative Planning |
13F
|
Company |
0.02%
|
19,018
|
$112,587 | — | 31 Mar 2024 | |
| Legacy Trust |
13F
|
Company |
0.02%
|
18,750
|
$111,000 | — | 31 Mar 2024 | |
| Mariner, LLC |
13F
|
Company |
0.02%
|
17,486
|
$103,517 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.02%
|
14,594
|
$86,396 | — | 31 Mar 2024 | |
| A. Brian Davis |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
12,900
|
$83,721 | — | 04 Jun 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.01%
|
11,654
|
$68,992 | — | 31 Mar 2024 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.01%
|
11,500
|
$68,000 | — | 31 Mar 2024 | |
| TRUIST FINANCIAL CORP |
13F
|
Company |
0.01%
|
10,545
|
$62,426 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
10,342
|
$61,225 | — | 31 Mar 2024 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
10,288
|
$60,905 | — | 31 Mar 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
9,769
|
$57,832 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
8,749
|
$51,794 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
7,738
|
$45,809 | — | 31 Mar 2024 | |
| Spire Wealth Management |
13F
|
Company |
0.01%
|
5,650
|
$33,448 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
3,805
|
$22,525 | — | 31 Mar 2024 | |
| Salomon & Ludwin, LLC |
13F
|
Company |
0%
|
2,900
|
$17,168 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
2,481
|
$15,000 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
2,526
|
$14,954 | — | 31 Mar 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
2,289
|
$13,000 | — | 31 Mar 2024 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0%
|
2,099
|
$12,426 | — | 31 Mar 2024 |
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q2 2024
As of 30 Jun 2024,
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,643,979 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, VANGUARD GROUP INC, BlackRock Inc., FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Propel Bio Management, LLC, Invesco Ltd., and Simplify Asset Management Inc..
This page lists
73
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
61
Q2 2024 holders
73
Holder diff
12
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.